- About PharmAbcine
- Company Overview
PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal
antibody (mAb) using innovative discovery technology and excellent human resources
for the treatment of human diseases, such as cancer and inflammatory diseases. Our mission is
to develop a first-in-class and best-in-class mAb for those target diseases.
PharmAbcine's vision is to establish a pharmaceutical business of mAb for better medicine. In the near future (< 5 years), we plan to enter the antibody drug market with our proprietary pipelines. In the long term business (> 10 years), we consider expanding our size for better service by M&A.
PharmAbcine's business is mainly focused on out-licensing of candidate therapeutics and clinical application.
For this purpose, we builds competitive pipelines & drug discovery platform by in-house approach. When necessary, we consider extending strategic partnership for win-win business model.
Our management team has expertise in all aspects of therapeutic antibody discovery and development, including marketing and we are also supported by world-class scientific advisors who are thought leaders in biology and medicine.